IP Verse

Stada Arzneimittel competitive analysis

Latest publications and patents of Stada Arzneimittel New

Explore the latest publications and patents granted to Stada Arzneimittel, showcasing their recent innovations and technological advancements.

Last updated on: Sep 29, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Stada Arzneimittel

EP3324936
Sep 28, 2022Method For Producing A Bortezomib Ester SolutionGranted And Under Opposition
EP3324937
Aug 17, 2022Ready-To-Use Bortezomib SolutionGranted And Under Opposition
EP2233127
May 27, 2020Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-RadiationsGranted And Under Opposition
EP1591105
May 27, 2020Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-RadiationsRevoked

Latest oppositions filed by Stada Arzneimittel

Explore patent oppositions filed by Stada Arzneimittel against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4218732
Tablets Comprising Eltrombopag OlamineNOVARTISAug 5, 2025
EP4125903
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 1, 2025
EP2662094
Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025
EP3781132
Apixaban FormulationsBRISTOL MYERS SQUIBBDec 19, 2024
EP3628319
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 13, 2024
EP2395968
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 17, 2024
EP3478286
Methods Of Treating Ovarian CancerTESAROOct 2, 2024
EP3494972
Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 11, 2024
EP3744326
Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICASep 5, 2024
EP3581183
Tumor-Treating Pharmaceutical CompositionEISAI R&D MANAGEMENTAug 29, 2024

Latest patents of Stada Arzneimittel opposed by its competitors

Explore Stada Arzneimittel's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3324936
Sep 28, 2022Method For Producing A Bortezomib Ester Solution6
EP3324937
Aug 17, 2022Ready-To-Use Bortezomib Solution7
EP1591105
May 27, 2020Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations6
EP2233127
May 27, 2020Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations9

Latest PTAB cases involving Stada Arzneimittel

Discover the latest PTAB cases involving Stada Arzneimittel, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Stada Arzneimittel with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
STADA ARZNEIMITTEL10828 - - Highly Aggressive
BEIERSDORF59125 - - Balanced
NOVARTIS6406 - 21Defensive
PFIZER51864312Aggressive